I honestly don't even know where to start with this one, but I suppose I'll just dive right in. Grace Fowler says:
My dad, who just turned 55, was diagnosed with lung cancer last week. Based on the initial tests and findings we've received so far, there's a possibility that this might actually be linked to melanoma or perhaps even hepatocellular carcinoma.
Melanoma most commonly spreads to the lungs, the liver, or the brain. If that's what we're looking at with your dad, there's actually some good news regarding those specific locations—the prognosis is generally better when it reaches those areas. I’ve been spending a lot of time reading through stories on an American melanoma survivor forum, catching up on the experiences of people who have faced this exact situation and are still here with us today. Just try to hang in there and keep a positive mindset.
Things haven't really changed on our end—my husband has decided he isn't going to push for any more biopsies or having additional lymph nodes removed for the time being. For now, he’s just sticking to his regular ultrasound checkups and waiting on the PET/CT scan scheduled for May. That date will be here before we know it, and honestly, only God knows what those results are going to show, which is why I find myself praying to Him every single day.
I’m actually reaching out today because there’s a bit of news worth sharing from issue number 67 of Medical News. There is a research project happening over in Denver that involves a collaboration with Ford, all backed by funding from the European Union. This initiative has been underway for a while now, and honestly, the results they are seeing are nothing short of fascinating. They are working on electrochemotherapy, which is currently being used to treat melanoma and various skin cancers, though the hope is that they can eventually expand this to other types of carcinoma as well. Skin tumors are the most practical starting point since the method essentially works by using electrodes to deliver electrical currents directly into the tumor mass. Once those currents have destabilized the cancer cells, they follow up with targeted, local chemotherapy. As I mentioned, the outcomes are truly incredible; they saw a complete regression of treated tumors in 48% of patients, even though every single one of them was already at stage IV. Now, I should clarify that this doesn't necessarily mean a total cure, since we aren't able to treat metastases within internal organs yet—so when we talk about remission here, we are specifically referring to the regression of metastases in the skin, subcutaneous tissue, and lymph nodes. In one particular case involving a woman, she maintained remission for eight years before experiencing a recurrence, but she has since undergone treatment again and her progress is being closely monitored. When you look at the standard statistics for melanoma, what they've achieved is an unbelievable success. Personally, I am still holding out high hopes that DCVax will be successful so that we won't have to keep searching for a cure, but it sure is comforting to know that these other options are out there.
I would have posted the link here, but I just can't seem to track down the latest issue of LN online anywhere.